EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations

Yue Hao, Zhengbo Song

International Open Medical Journal (IOMJ) · 09.11.2026 · 2 · 255-258

DOI: 10.65364/iomj.2026.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Open Medical Journal (IOMJ), online erschienen am 09.11.2026. Verfasst von Yue Hao und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

none

Zitieren

APA

Hao, Y., & Song, Z. (2026). Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations. International Open Medical Journal (IOMJ), 2, 255-258. https://doi.org/10.65364/iomj.2026.17

Vancouver

Hao Y, Song Z. Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations. International Open Medical Journal (IOMJ). 2026;2:255-258. doi:10.65364/iomj.2026.17

BibTeX
@article{Hao2026,
  author = {Hao, Yue and Song, Zhengbo},
  title = {Beyond a Single KRAS Inhibitor: China-Originated Therapeutics and the Rise of Resistance-Directed Combinations},
  journal = {International Open Medical Journal (IOMJ)},
  year = {2026},
  volume = {2},
  pages = {255--258},
  doi = {10.65364/iomj.2026.17}
}
Kostenlos starten →